In two randomized, placebo-controlled trials of three Ebola vaccine administration regimens for adults and children, the Partnership for Research on…
Following up on a National Institute of Allergy and Infectious Diseases (NIAID) Notice of Special Interest from November that sought…
Following a two-year investigation by U.S. Sen. Gary Peters (D-MI), chairman of the Senate Homeland Security and Governmental Affairs Committee,…
A partnership between VBI Vaccines Inc. and the Coalition for Epidemic Preparedness Innovations (CEPI) expanded this week with a new…
As part of its Antiviral Program for Pandemics (APP), meant to accelerate the discovery, development, and manufacturing of antivirals, the…
Capitalistic values continue to hinder vaccine development, according to the World Health Organization’s (WHO) first report on the global vaccine…
Pfizer and BioNTech announced updates from a Phase 2/3 clinical trial of their bivalent booster for the COVID-19 variants Omicron…
Biopharmaceutical company Soligenix, Inc. recently received an invitation from the Biomedical Advanced Research and Development Authority (BARDA) to submit a…
Coalition for Epidemic Preparedness Innovations (CEPI) and SK bioscience personnel are touting a collaboration to facilitate rapid response to unknown…
Through a new licensing agreement between Merck and the Bill & Melinda Gates Medical Research Institute, two preclinical antibacterial candidates…
This website uses cookies.